Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J buys bowel drug license option from Isis Pharma for $835 mln
J&J buys bowel drug license option from Isis Pharma for $835 mln
J&J buys bowel drug license option from Isis Pharma for $835 mln
Submitted by
admin
on January 5, 2015 - 9:07am
Source:
Yahoo/Reuters
News Tags:
JNJ
Isis Pharmaceuticals
autoimmune disease
inflammatory bowel disease
Headline:
J&J buys bowel drug license option from Isis Pharma for $835 mln
Do Not Allow Advertisers to Use My Personal information
